Related references
Note: Only part of the references are listed.Updates on novel pharmacotherapeutics for the treatment of nonalcoholic steatohepatitis
Yong-yu Yang et al.
ACTA PHARMACOLOGICA SINICA (2022)
Autophagy restricts mitochondrial DNA damage-induced release of ENDOG (endonuclease G) to regulate genome stability
Tung Chao et al.
AUTOPHAGY (2021)
Evaluation of Apelin/APJ system expression in hepatocellular carcinoma as a function of clinical severity
Manuela Cabiati et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2021)
The changing scenario of hepatocellular carcinoma in Italy: an update
Francesca Garuti et al.
LIVER INTERNATIONAL (2021)
Inflammatory Mechanisms Underlying Nonalcoholic Steatohepatitis and the Transition to Hepatocellular Carcinoma
Moritz Peiseler et al.
CANCERS (2021)
Do pentraxin 3 and neural pentraxin 2 have different facet function in hepatocellular carcinoma?
Manuela Cabiati et al.
CLINICAL AND EXPERIMENTAL MEDICINE (2021)
Bcl-2 Associated Athanogene 2 (BAG2) is Associated With Progression and Prognosis of Hepatocellular Carcinoma: A Bioinformatics-Based Analysis
Xi Zhang et al.
PATHOLOGY & ONCOLOGY RESEARCH (2021)
Role of Apelin/APJ axis in cancer development and progression
Javad Masoumi et al.
ADVANCES IN MEDICAL SCIENCES (2020)
Biomarkers in Hepatocellular Carcinoma: Diagnosis, Prognosis and Treatment Response Assessment
Federico Pinero et al.
CELLS (2020)
Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Zobair Younossi et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2019)
Bioinformatics analysis to identify the key genes affecting the progression and prognosis of hepatocellular carcinoma
Yingai Zhang et al.
BIOSCIENCE REPORTS (2019)
Pyridine nucleotide-disulphide oxidoreductase domain 2 (PYROXD2): Role in mitochondrial function
Tao Wang et al.
MITOCHONDRION (2019)
Growth arrest-specific gene 2 suppresses hepatocarcinogenesis by intervention of cell cycle and p53-dependent apoptosis
Ran-Xu Zhu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2019)
New insight into BIRC3: A novel prognostic indicator and a potential therapeutic target for liver cancer
Pei-Yao Fu et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Predisposition to Apoptosis in Hepatocellular Carcinoma: From Mechanistic Insights to Therapeutic Strategies
Jens U. Marquardt et al.
FRONTIERS IN ONCOLOGY (2019)
Overexpression of apoptosis-inducing factor mitochondrion-associated 1 (AIFM1) induces apoptosis by promoting the transcription of caspase3 and DRAM in hepatoma cells
Dongjie Liu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2018)
Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis
Kristina Tzartzeva et al.
GASTROENTEROLOGY (2018)
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle et al.
JOURNAL OF HEPATOLOGY (2018)
Pentraxin 3 overexpression accelerated tumor metastasis and indicated poor prognosis in hepatocellular carcinoma via driving epithelial-mesenchymal transition
Tao Song et al.
JOURNAL OF CANCER (2018)
HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas
Qiuyu Lian et al.
GENOMICS PROTEOMICS & BIOINFORMATICS (2018)
Hepatitis C virus-induced hepatocellular carcinoma: a narrative review
Maja Ruzic et al.
PANMINERVA MEDICA (2018)
GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses
Zefang Tang et al.
NUCLEIC ACIDS RESEARCH (2017)
Increased FNDC5/Irisin expression in human hepatocellular carcinoma
Melania Gaggini et al.
PEPTIDES (2017)
Recurrently deregulated lncRNAs in hepatocellular carcinoma
Yang Yang et al.
NATURE COMMUNICATIONS (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
Osteopontin in hepatocellular carcinoma: A possible biomarker for diagnosis and follow-up
Manuela Cabiati et al.
CYTOKINE (2017)
Genetic variation in PTX3 and plasma levels associated with hepatocellular carcinoma in patients with HCV
R. F. Carmo et al.
JOURNAL OF VIRAL HEPATITIS (2016)
RANK-RANKL signalling in cancer
Nathalie Renema et al.
BIOSCIENCE REPORTS (2016)
Integrative Genomic Analysis Identifies the Core Transcriptional Hallmarks of Human Hepatocellular Carcinoma
Coralie Allain et al.
CANCER RESEARCH (2016)
Alcoholic Liver Disease High Risk or Low Risk for Developing Hepatocellular Carcinoma?
Kartik Joshi et al.
CLINICS IN LIVER DISEASE (2016)
Metabolomics: beyond biomarkers and towards mechanisms
Caroline H. Johnson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2016)
CoINcIDE: A framework for discovery of patient subtypes across multiple datasets
Catherine R. Planey et al.
GENOME MEDICINE (2016)
Genetic Landscape and Biomarkers of Hepatocellular Carcinoma
Jessica Zucman-Rossi et al.
GASTROENTEROLOGY (2015)
Biomarkers for the early diagnosis of hepatocellular carcinoma
Nobuhiro Tsuchiya et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2015)
EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
et al.
JOURNAL OF HEPATOLOGY (2015)
Neuronal Pentraxin 2 Supports Clear Cell Renal Cell Carcinoma by Activating the AMPA-Selective Glutamate Receptor-4
Christina A. von Roemeling et al.
CANCER RESEARCH (2014)
Effects of RANKL-targeted therapy in immunity and cancer
Michael L. Cheng et al.
FRONTIERS IN ONCOLOGY (2014)
The role of Bcl-2 and its pro-survival relatives in tumourigenesis and cancer therapy
P. N. Kelly et al.
CELL DEATH AND DIFFERENTIATION (2011)
Risk Assessment of Hepatitis B Virus-Related Hepatocellular Carcinoma Development Using Liver Stiffness Measurement (FibroScan)
Kyu Sik Jung et al.
HEPATOLOGY (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
Expression Pattern of Receptor Activator of NFκB (RANK) in a Series of Primary Solid Tumors and Related Bone Metastases
Daniele Santini et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function
David Warde-Farley et al.
NUCLEIC ACIDS RESEARCH (2010)
Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma
Yujin Hoshida et al.
CANCER RESEARCH (2009)
The MIQE Guidelines: Minimum Information for Publication of Quantitative Real-Time PCR Experiments
Stephen A. Bustin et al.
CLINICAL CHEMISTRY (2009)
Incidence of Hepatocellular Carcinoma and Associated Risk Factors in Hepatitis C-Related Advanced Liver Disease
Anna S. Lok et al.
GASTROENTEROLOGY (2009)
Receptor activator of nuclear Factor-κB ligand (RANKL) expression in hepatocellular carcinoma with bone metastasis
Atsushi Sasaki et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Apoptosis: A review of programmed cell death
Susan Elmore
TOXICOLOGIC PATHOLOGY (2007)
Prevention of hepatitis B virus-related hepatocellular carcinoma
ASF Lok
GASTROENTEROLOGY (2004)
α-fetoprotein and ultrasonography screening for hepatocellular carcinoma
B Daniele et al.
GASTROENTEROLOGY (2004)
Role of osteopontin in tumour progression
SR Rittling et al.
BRITISH JOURNAL OF CANCER (2004)
Hepatocellular carcinoma: Diagnosis and treatment
AS Befeler et al.
GASTROENTEROLOGY (2002)
Differential regulation of P53, c-Myc, Bcl-2, Bax and AFP protein expression, and caspase activity during 10-hydroxycamptothecin-induced apoptosis in Hep G2 cells
XW Zhang et al.
ANTI-CANCER DRUGS (2000)
Share Paper
